diabetes
Lily increases diabetes drug by 700% over 20 years
November 3, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bernie Sanders, Eli Lily, Humalog, diabetes
It has come to light that, over a 20 year period, Eli Lily has increased the price of its diabetes …
NICE recommends Forxiga in Triple Therapy for Diabetes
October 7, 2016Medical Communications AstraZeneca, Forxiga, NHS, NICE, diabetes, type 2 diabetes
The news of NICE’s approval of the Forxiga comes in a busy week for AstraZeneca. They have sold three drugs, …
Patients’ insulin pumps are revealed to be hackable by J&J
October 4, 2016Research and Development, Sales and Marketing FDA, Hackers, Johnson & Johnson, diabetes, insulin
Johnson & Johnson have begun warning patients that their insulin pumps, that patients attach to their bodies and are controlled …
Novo Nordisk to cut 2% of its entire workforce
September 29, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Denmark, Novo Nordisk, diabetes, insulin, job cuts, job losses
Novo Nordisk, headquartered in Bagsvaerd, Denmark, has taken the decision to lose 1,000 of its workforce from a total global …
Novo Nordisk to provide discounted insulin to poorest nations
September 23, 2016Medical Communications, Sales and Marketing Novo Nordisk, diabetes, insulin
Danish pharma firm Novo Nordisk has announced its intention to provide insulin at discounted prices to the world’s poorest nations …
Novo Nordisk’s diabetes drug “significantly reduced’ cardiovascular risk
September 16, 2016Medical Communications Novo Nordisk, diabetes, semaglutide
Novo Nordisk has announced that its diabetes drug semaglutide “significantly reduced” the risk of major cardiovascular events at the 52nd …
Sanofi and Google forge $500 million diabetes partnership
September 12, 2016Research and Development, Sales and Marketing Alphabet, Sanofi, Verily, diabetes, google
Sanofi is set to join forces with Alphabet’s life sciences firm Verily in a $500 million partnership to develop diabetes …
Roche launches ‘next-generation’ blood glucose monitoring system
August 23, 2016Manufacturing and Production, Sales and Marketing Roche, blood glucose monitoring, diabetes
Roche has announced the launch of its new Accu-Chek Guide blood glucose monitoring system. The system promises to simplify everyday …
FDA delays appraisal of Sanofi, Zealand diabetes drug just days before decision due
August 22, 2016Research and Development, Sales and Marketing NDA, Sanofi, appraisal, diabetes, iglarlixi, type 2, type-2, zealand
There was unfortunate news for Sanofi and Zealand Pharma as the FDA announced that it required additional information, constituting a …
Promising results for new type 2 diabetes management procedure
August 12, 2016Research and Development, Sales and Marketing Fractyl, Revita, diabetes, type 2 diabetes
Fractyl Laboratories has revealed data from its first-in-human study of Revita duodenal mucosal resurfacing (Revita DMR), a new 60-minute, non-surgical …
Novo Nordisk diabetes drug Victoza fails to reduce heart failure risk
August 5, 2016Medical Communications, Research and Development Eli Lily, Novo Nordisk, Victoza, diabetes, heart failure
Novo Nordisk’s diabetes drug Victoza (liraglutide), which was found to cut cardiovascular risks in sufferers of heart disease, has failed …
Sanofi gets FDA approval for type-2 diabetes treatment Adlyxin
July 28, 2016Research and Development, Sales and Marketing FDA, Lixisenatide, Lyxumia, Sanofi, adlyxin, approval, diabetes, type 2, type-2, zealand
Sanofi has announced that the US Food and Drug Administration (FDA) has approved Adlyxin (lixisenatide), which is a once-daily mealtime …
Eli Lilly says FDA panel backs approval of Jardiance for cardiovascular indication
June 30, 2016Research and Development, Sales and Marketing Eli Lilly, cardiovascular, diabetes, jardiance
US drugmaker Eli Lilly (NYSE: LLY) said a US regulatory panel has backed its Jardiance (empagliflozin) for reducing cardiovascular death …
Lilly showcases positive late-stage data in diabetes treatments
June 13, 2016Research and Development, Sales and Marketing diabetes, lilly
Eli Lilly (NYSE: LLY) has presented data on their diabetes drugs in late-stage trials at the 76th American Diabetes Association …
FDA approves Lilly/Boehringer Ingelheim type-2 diabetes drug
June 1, 2016Research and Development, Sales and Marketing Boehringer Ingelheim, Eli Lilly, FDA, diabetes, jentadueto, jentadueto xr, lilly, partnership, type 2, type-2
The US Food and Drug Administration (FDA) has approved Jentadueto XR (linagliptin and metformin hydrochloride extended release) tablets for the …
